Evidence map›Paper›PMID 32725155›Full record

ArticleBioscience reports2020

Loss of Mef2D function enhances TLR induced IL-10 production in macrophages.

Michael J Pattison, Rangeetha Jayaprakash Naik, Kathleen M S E Reyskens, J Simon C Arthur

Open access · goldAbstract read
In one paragraph

Article in Bioscience reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.7field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. The Molecular and Biological Function of MEF2D in Leukemia.Advances in experimental medicine and biology · 2024
    Review
  3. Article
  4. Article
  5. Article
  6. microLife · 2023
    Article
  7. Article
  8. ERK1/2 in immune signalling.Biochemical Society transactions · 2022
    Review
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Michael J Pattison *Division of Cell Signalling and Immunology, Wellcome Trust Building, School of Life Sciences, University of Dundee, Dow St, Dundee, DD5 1EH, U.K.
Rangeetha Jayaprakash Naik *Division of Cell Signalling and Immunology, Wellcome Trust Building, School of Life Sciences, University of Dundee, Dow St, Dundee, DD5 1EH, U.K.
Kathleen M S E ReyskensDivision of Cell Signalling and Immunology, Wellcome Trust Building, School of Life Sciences, University of Dundee, Dow St, Dundee, DD5 1EH, U.K.
J Simon C ArthurDivision of Cell Signalling and Immunology, Wellcome Trust Building, School of Life Sciences, University of Dundee, Dow St, Dundee, DD5 1EH, U.K.
University of Dundee · GB

Funding

Medical Research Council MR/L008785/1
6 · The paper itself

Abstract

Mef2 transcription factors comprise a family of four different isoforms that regulate a number of processes including neuronal and muscle development. While roles for Mef2C and Mef2D have been described in B-cell development their role in immunity has not been extensively studied. In innate immune cells such as macrophages, TLRs drive the production of both pro- and anti-inflammatory cytokines. IL-10 is an important anti-inflammatory cytokine produced by macrophages and it establishes an autocrine feedback loop to inhibit pro-inflammatory cytokine production. We show here that macrophages from Mef2D knockout mice have elevated levels of IL-10 mRNA induction compared with wild-type cells following LPS stimulation. The secretion of IL-10 was also higher from Mef2D knockout macrophages and this correlated to a reduction in the secretion of TNF, IL-6 and IL-12p40. The use of an IL-10 neutralising antibody showed that this reduction in pro-inflammatory cytokine production in the Mef2D knockouts was IL-10 dependent. As the IL-10 promoter has previously been reported to contain a potential binding site for Mef2D, it is possible that the binding of other Mef2 isoforms in the absence of Mef2D may result in a higher activation of the IL-10 gene. Further studies with compound Mef2 isoforms would be required to address this. We also show that Mef2D is highly expressed in the thymus, but that loss of Mef2D does not affect thymic T-cell development or the production of IFNγ from CD8 T cells.

Indexed as

AnimalsCells, CulturedInflammation MediatorsInterleukin-10LipopolysaccharidesMacrophagesMEF2 Transcription FactorsMice, Inbred C57BLMice, KnockoutT-LymphocytesToll-Like ReceptorsUp-RegulationIL10 protein, mouseInflammation MediatorsInterleukin-10LipopolysaccharidesMef2d protein, mouseMEF2 Transcription FactorsToll-Like Receptorsintracellular signalingmacrophagesmef2Dtoll-like receptors

Identifiers

PMID32725155
PMCPMC7442974
OpenAlexW3046113195

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.